[Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004415:Dyspepsia / Q000139:chemically induced / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D016595:Misoprostol / Q000627:therapeutic use*; D009853:Omeprazole / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000517:prevention & control*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D016861:Cyclooxygenase Inhibitors; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D016595:Misoprostol; D009853:Omeprazole
Prävention von Ulkusläsionen unter NSAR. Für jeden Patienten der passende Magenschutz.